Vimab Group AB (OSTO:VIMAB) 5-Year EBITDA Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:VIMAB Vimab Group AB OSTO:VIMAB
54 GF Score
Price kr3.86
GF Value kr5.51
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Vimab Group AB 5-Year EBITDA Growth Rate?

Vimab Group AB OSTO:VIMAB +2.66% 54 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates OSTO:VIMAB with a GF Score™ of 54/100 and a GF Value™ of kr5.51 (Possible Value Trap). The stock has 4 warning signs investors should review.

Vimab Group AB's EBITDA per Share for the three months ended in Jun. 2026 was kr0.17.

During the past 3 years, the average EBITDA Per Share Growth Rate was -18.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Vimab Group AB was 88.80% per year. The lowest was -18.70% per year. And the median was 2.50% per year.

Vimab Group AB  (OSTO:VIMAB) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Vimab Group AB 5-Year EBITDA Growth Rate Related Terms

OSTO:VIMAB vs VRSK, EFX, BAH: 5-Year EBITDA Growth Rate Comparison

For the Consulting Services subindustry, Vimab Group AB's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vimab Group AB 5-Year EBITDA Growth Rate vs Business Services Industry

For the Business Services industry and Industrials sector, Vimab Group AB's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Vimab Group AB's 5-Year EBITDA Growth Rate falls into.


OSTO:VIMAB
54GF Score
Vimab Group AB OSTO:VIMAB
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vimab Group AB 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Vimab Group AB (OSTO:VIMAB) has a 5-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Vimab Group AB and its competitors.
Is Vimab Group AB's 5-Year EBITDA Growth Rate too high?
Vimab Group AB's current 5-Year EBITDA Growth Rate is 0.00%. Overall, Vimab Group AB has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's 5-Year EBITDA Growth Rate compare to VRSK and EFX?
Vimab Group AB's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Business Services company?
A good 5-Year EBITDA Growth Rate depends on the Business Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Vimab Group AB and its competitors. Vimab Group AB's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Based on GuruFocus' analysis, Vimab Group AB (OSTO:VIMAB) is currently considered Possible Value Trap. The stock's GF Value™ is kr5.51, compared to a current price of kr3.86 — trading 29.9% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. Vimab Group AB's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Vimab Group AB (OSTO:VIMAB), the current 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued. The current stock price of kr3.86 is trading 29.9% below its estimated GF Value™ of kr5.51. GuruFocus considers Vimab Group AB to be Possible Value Trap.

Key valuation signals for OSTO:VIMAB:

  • 5-Year EBITDA Growth Rate: 0.00%
  • GF Value™: kr5.51 vs. price of kr3.86 (29.9% below fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vimab Group AB Business Description

Address Malmskillnadsgatan 40A, Stockholm, SWE, 111 57
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
54GF Score

Get the complete analysis for OSTO:VIMAB

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.86
Price
kr5.51
GF Value